0
samples (3, 4) , and therefore could be a valuable test for oral swab testing. In a small proof-of-concept pilot study we estimated the sensitivity and specificity of Mtb 4 5 detection from oral swabs using Xpert MTB/RIF ULTRA (Cepheid, Sunnyvale, USA). A second 4 6 3 aim of this pilot was to pilot three collection methods and storage procedures of swabs. In 4 7 addition to the method described previously (1,2), which requires preparation of a buffer, we 4 8 employed two other methods that could facilitate implementation of Xpert testing of oral swabs 4 9 in low-resource settings. We recruited 33 adults diagnosed with pulmonary TB from TB clinics in Lima, Peru prior to 5 3 anti-TB treatment initiation. Thirty controls (i.e., clinic attendees with no respiratory symptoms) 5 4
were recruited from the same health centers. Participants were randomly assigned to one of three 5 5 sample collection groups to assess collection methods and storage procedures: 1. .Omniswab 5 6 (Whatman, catalog #WB100035) in lysis buffer as described in (1,2); 2. Omniswab in phosphate 5 7 buffered saline (PBS); 3. Sample capture on FTA cards (Whatman catalog #120237). We negative in smear microscopy. The overall sensitivity for oral swab detection was 45% (95% 7 0 confidence interval (CI): 29%-63%), with positive tests for 15/33 TB patients (Table 1) . We resulting in Mtb detection in 6 of 10 patients, followed by FTA and PBS cards (5/13 and 4/10 7 5 respectively). Specificity was 100% for all groups (95% CI: 84.0%-100%), (26/26 of controls 7 6 tested negative; 4 tests had invalid results due to power interruption). Three of the 33 patients were diagnosed with drug resistant TB based on culture-based drug 8 1 sensitivity testing. We confirmed rifampin resistance with Xpert oral swab analysis for one of 8 2 these patients, Mtb was not detected in the swabs of the other two patients. reported that Omniswab tongue swabs yielded significant better results compared to cheek 8 7 swabs, with a sensitivity of 71.2% for a single swab and 83.1% for two swabs in 59 patients 8 8
